The extracts known as fucoidans are biological compounds that have been found to contain anti-cancer, anti-inflammatory, anti-viral, immunity and gut boosting properties.

The trial conducted between the Brisbane Lions, Griffith University and Marinova seeks to examine the effects of fucoidans on the microbiome of athletes.  

Marinova communications manager Claire Smoorenburg said previous research has shown that fucoidans balance good and bad microbiome, reduce inflammation and inhibit viruses and bacteria. 

She said microbiome refers to the full collection of micro organisms that live in the gut, and which are unique to every person. 

“The gut microbiome is very important for immune function and general health.  It has been found that intense exercise by elite athletes can cause inflammation in the gut, basically destabilising  the microbiome, which can compromise the athlete’s ability to train and recover,” she said.

“We believe this fucoidan trial will show positive effects on the gut.  We are trying to increase the diversity of the microbiome, which is going to lead to stronger immunity and better health.” 

The Brisbane Lions team will take fucoidan capsules every day for seven months, with faecal samples to be taken one week after the trial starts and again at the seven month mark. 

Brisbane Lions sports dietician Pip Taylor said the team was excited to be taking part in this cutting edge sports research.

“The study outcomes will provide insight into how this natural product can keep our players in prime health and assist them in adapting to their intensive playing and training regimes.”

Fucodians used in the trial will be extracted from the undaria and ficus bladderwreck seaweed species, from plants grown in Patagonia.